Stuart Mest, MD | |
811 Sunset Rd, Suite 201, Burlington, NJ 08016-3645 | |
(609) 298-1776 | |
(609) 531-2391 |
Full Name | Stuart Mest |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 811 Sunset Rd, Burlington, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720080559 | NPI | - | NPPES |
2403307 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA05310200 (New Jersey) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 25MA05310200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stuart Mest, MD 500 Grove St, Suite 100, Haddon Heights, NJ 08035-1761 Ph: (856) 796-9200 | Stuart Mest, MD 811 Sunset Rd, Suite 201, Burlington, NJ 08016-3645 Ph: (609) 298-1776 |
News Archive
In a New England Journal of Medicine "Perspective" published today, Wafaa El-Sadr, MD, MPH, global director of ICAP at Columbia University Mailman School of Public Health, and Jessica Justman, MD, ICAP's senior technical director, and associate professor of epidemiology, urge a coordinated global effort in the face of the COVID-19 pandemic, with "countries around the world [taking] concrete steps to assist Africa in staying ahead of the curve, even as they confront their own epidemics."
Acne is a serious medical condition. More than 40 percent of mid-teens and adolescents have either acne or acne scarring requiring professional treatment by a dermatologist. Unfortunately, nationwide statistics show that only 11 percent of patients receive treatment.
The risk of traffic accidents is increased by 50% in patients with an implantable cardioverter defibrillator (ICD) compared to age and gender matched controls, according to a Danish nationwide registry study presented at ESC Congress 2016 today.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that the first participant in its Phase 1/2 clinical trial of RCT-01, being tested for the treatment of chronic unilateral Achilles tendinosis, has been enrolled and their tissue biopsy sent for processing prior to intra-tendon ultrasound-guided injections.
Researchers from the University of California, San Diego, have identified a protein that regulates a gene associated with schizophrenia. The study, published in the Journal of Neurophysiology, was chosen as an APS​select article for January.
› Verified 6 days ago
Daniel Robert Jordan, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 811 Sunset Rd, Suite 101, Burlington, NJ 08016 Phone: 609-387-9242 Fax: 609-387-1948 | |
Dr. Roopama Kamra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1105 Sunset Rd, Burlington, NJ 08016 Phone: 609-387-9242 Fax: 609-387-0304 | |
Dr. Scott M Dorfner, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 811 Sunset Rd, Burlington, NJ 08016 Phone: 609-877-4545 |